How to improve the management of a patient with heparin-induced thrombocytopenia?
- PMID: 31789608
- PMCID: PMC6955042
- DOI: 10.14744/AnatolJCardiol.2019.28455
How to improve the management of a patient with heparin-induced thrombocytopenia?
Comment in
-
Author`s Reply.Anatol J Cardiol. 2019;22(6):339-340. Anatol J Cardiol. 2019. PMID: 31789621 Free PMC article. No abstract available.
Comment on
-
Mitral valve and right ventricular thrombi possibly caused by heparin-induced thrombocytopenia.Anatol J Cardiol. 2019 Sep;22(4):206-209. doi: 10.14744/AnatolJCardiol.2019.65712. Anatol J Cardiol. 2019. PMID: 31584437 Free PMC article. No abstract available.
References
-
- Douketis J, Ageno W, Carrier M, Kearon C. Managing challenging patients with venous thromboembolism:a practical, case-based approach. Pol Arch Intern Med. 2017;127:41–6. - PubMed
-
- Bryk AH, Mazur P, Zdziarska J, Kuczia P, Plens K, Leśniak-Sobelga A, et al. Similar prevalence of platelet factor 4/heparin immunoglobulin G antibodies in patients following cardiac surgery and other patients suspected of heparin-induced thrombocytopaenia. Kardiol Pol. 2018;76:1372–5. - PubMed
-
- Chao CH, Wang HY, Kao CH. Occult cancer and thromboembolism:current epidemiology and its practical implications. Pol Arch Intern Med. 2018;128:539–44. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical